AMANDA HUNTER: Open Payments
NPI 1700242005 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,816 in 107 payments from 21 companies in 2025. Trend: 2023 $538 · 2024 $472 · 2025 $1,816
Food & beverage: $1,816
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $417 |
| Dexcom, Inc. | 21 | $266 |
| Abbott Laboratories | 10 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $181 |
| Amgen Inc. | 5 | $94 |
| SANOFI-AVENTIS U.S. LLC | 5 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $77 |
| Radius Health, Inc. | 3 | $72 |
| Ascendis Pharma Endocrinology Inc | 3 | $61 |
| Lilly USA, LLC | 3 | $57 |
Products named: Ozempic, Dexcom G6 Transmitter, FREESTYLE LIBRE, JARDIANCE, TZIELD, Kerendia, Tymlos, Yorvipath.
Industry payments across MO — which companies pay providers there.
